Showing results (171-180 of 216) with videos related to

Sort By:
Pageof 22
British Journal of Haematology|September 10, 2024
Integrating chemokines and machine learning algorithms for diagnosis and bleeding assessment in primary immune thrombocytopenia: A prospective cohort studyQing Wen, Ting Sun, Jia Chen, et al.
British Journal of Haematology|March 4, 2024
Metabolomics profile and machine learning prediction of treatment responses in immune thrombocytopenia: A prospective cohort studyYang Li, Ting Sun, Jia Chen, et al.
Blood|June 21, 2017
A novel recombinant human thrombopoietin therapy for the management of immune thrombocytopenia in pregnancyZhangyuan Kong, Ping Qin, Shan Xiao, et al.
Signal Transduction and Targeted Therapy|March 12, 2026
Phase 1 pilot study for hemophilia-A: AAV8 vector with prophylactic tacrolimus-glucocorticoid achieves therapeutic FVIII activityWei Liu, Xiaolei Pei, Tenghui Yu, et al.
Clinical and Experimental Medicine|July 7, 2024
Multi-omics differences in the bone marrow between essential thrombocythemia and prefibrotic primary myelofibrosisAnqi Zhang, Ting Sun, Dandan Yu, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 25, 2019
Health-related quality of life and health status in persons with haemophilia A with inhibitors: A prospective, multicentre, non-interventional study (NIS)Johnny Mahlangu, Johannes Oldenburg, Michael U Callaghan, et al.
Journal of Blood Medicine|December 3, 2020
Safety and Efficacy of Moroctocog Alfa (AF-CC) in Chinese Patients with Hemophilia A: Results of Two Open-Label StudiesRenchi Yang, Yongqiang Zhao, Xuefeng Wang, et al.
British Journal of Haematology|July 1, 2026
Clinical heterogeneity in congenital factor XII deficiency: Coexisting risk factors in thrombotic and bleeding eventsXinmiao Qu, Yujiao Jia, Yuhua Wang, et al.
Journal of Thrombosis and Haemostasis : JTH|February 16, 2023
Preclinical studies of a factor X activator and a phase 1 trial for hemophilia patients with inhibitorsWei Liu, Feng Xue, Rongfeng Fu, et al.
American Journal of Hematology|October 18, 2023
Single-dose rituximab plus glucocorticoid versus cyclophosphamide plus glucocorticoid in patients with newly diagnosed acquired hemophilia A: A multicenter, open-label, randomized noninferiority trialPanJing Wang, Rongfu Zhou, Feng Xue, et al.
Pageof 22